// App-Quantinova.ai

15942 : Low Agreement of 18F-Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) and Cardiac Magnetic Resonance (CMR) in Patients With Conduction Disease Due to Cardiac Sarcoidosis

Researchers

Presenter

  • David Birnie

Principal Investigators

  • Ross Davies

  • Ran Klein

  • Ann Guo

  • Linda Garrard

  • Terrence Ruddy

  • Benjamin Chow

  • Renee Hessian

  • Kori Kingsbury

  • Rob S Beanlands

  • Pablo Nery

  • Eugene Leung

  • Keiichiro Yoshinaga

  • Ichizo Tsujino

  • Takahiro Sato

  • Jordan Bernick

  • Osamu Manabe

  • Masaharu Nishimura

  • Nagara Tamaki

Medical Centers

  • Hokkaido Univ Graduate Sch of Med, Sapporo, Japan

  • Cardiac Care Network of Ontario, North York, ON, Canada

  • University of Ottawa Heart Institute, Ottawa, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

Locations

  • Canada

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Cardiac sarcoidosis

  • Progressive cardiac conduction defect

  • Sarcoidosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim